The Motley Fool Discussion Boards
Industry Discussions / Biotechnology
|Subject: dsco||Date: 3/7/2012 12:48 PM|
|Author: shuksan77||Number: 24826 of 25054|
Ah, my sad history, sort of, with DSCO.
Which raises the daunting question of if and when to buy and sell biotechs.
I bought and sold in 2001, made a little money. This was on the promise of Surfaxin. Nothing much happened.
Bought and sold in 2003. Made a little money. Still on promise of Surfaxin. Nothing much happened--though the stock's price was a couple of bucks higher than it is now--even after approval. (Nothing to this,though, this often happens).
9-11 years later the cmpd gets the ok--after four tries--and the stock doesn't do much.
One problem is that the addressable mkt isn't really that big--as these things go, so there is that.
I guess the best bet is to await approval and commercialization in big markets. This reduces the biggest potential gains but prevents catastrophic failures...
--WHo is still awaiting the best diet pill....
|Copyright 1996-2017 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|